DOI: https://dx.doi.org/10.18565/therapy.2023.7.17-21
Lagutina S.N., Chizhkov P.A., Zuykova A.A., Dobrynina I.S., Popov V.N.
1) N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia; 2) Voronezh State University
1. Lin L., Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunology. 2017; 18(1): 2. https://dx.doi.org/10.1186/s12865-016-0187-3. 2. Derovs A., Laivacuma S., Krumina A. Targeting microbiota: What do we know about it at present? Med (Kaunas). 2019; 55(8): 459. https://dx.doi.org/10.3390/medicina55080459. 3. Burakova I., Smirnova Y., Gryaznova M. et al. The effect of short-term consumption of lactic acid bacteria on the gut microbiota in obese people. Nutrients. 2022; 14(16): 3384. https://dx.doi.org/10.3390/nu14163384. 4. Chattopadhyay I., Dhar R., Petusami K. et al. Exploring the role of the gut microbiome in colon cancer. Applied Biochemistry Biotechnol. 2021; 193(6): 1780–99. https://dx.doi.org/10.1007/s12010-021-03498-9. 5. Loke Y.L., Chew M.T., Ngeow Y.F. et al. Colon carcinogenesis: The interplay between diet and gut microbiota. Front Cell Infect Microbiol. 2020; 10: 603086. https://dx.doi.org/10.3389/fcimb.2020.603086. 6. Sanchez-Alcoholado L., Ramos-Molina B., Otero A. et al. The role of the gut microbiome in colorectal cancer development and therapy response. Cancers (Basel). 2020; 12(6): 1406. https://dx.doi.org/10.3390/cancers12061406. 7. Sekizuka T., Ogasawara Y., Ohkusa T., Kuroda M. Characterization of Fusobacterium varium Fv113-g1 isolated from a patient with ulcerative colitis based on complete genome sequence and transcriptome analysis. PLoS One. 2017; 12(12): e0189319. https://dx.doi.org/10.1371/journal.pone.0189319.
Svetlana N. Lagutina, resident of the Department of outpatient therapy, N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia. Address: 394036, Voronezh, 10 Studencheskaya Str. E-mail: svlagutina97@mail.ru. ORCID: https://orcid.org/0000-0003-3730-5265
Pavel A. Chizhkov, postgraduate student of the Department of genetics, cytology and bioengineering, Voronezh State University. Address: 394018, Russia, Voronezh, 1 Universitetskaya Sq. E-mail: qooleer@yandex.ru.
ORCID: https://orcid.org/0000-0002-5626-0579
Anna A. Zuikova, MD, professor, head of the Department of polyclinic therapy, N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia. Address: 394036, Voronezh, 10 Studencheskaya Sq. E-mail: zuikova-therapia@vrngmu.ru. ORCID: https://orcid.org/0000-0002-5378-4959
Irina S. Dobrynina, PhD in Medical Sciences, associate professor of the Department of polyclinic therapy, N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia. Address: 394036, Voronezh, 10 Studencheskaya Sq. E-mail: dobrynina@mail.ru. ORCID: https://orcid.org/0000-0002-4849-0200
Vasily N. Popov, MD, professor, head of the Department of genetics, cytology and bioengineering, N.N. Burdenko Voronezh State Medical University of the Ministry of Healthcare of Russia. Address: 394036, Voronezh, 10 Studencheskaya Sq. E-mail: pvn@vsuet.ru. ORCID: https://orcid.org/0000-0003-1294-8686